Zevra Therapeutics, Inc. (FRA:1GDA)

Zevra Therapeutics Revenue

Zevra Therapeutics had revenue of $26.06M USD in the quarter ending September 30, 2025, with 605.36% growth. This brings the company's revenue in the last twelve months to $84.39M, up 244.60% year-over-year. In the year 2024, Zevra Therapeutics had annual revenue of $23.61M, down -14.02%.

• Revenue (ttm): $84.39M
• Revenue Growth: +244.60%
• P/S Ratio: 5.93
• Revenue / Employee: $1.43M
• Employees: 59
• Market Cap: 426.47M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	23.61M	-3.85M	-14.02%
Dec 31, 2023	27.46M	17.00M	162.58%
Dec 31, 2022	10.46M	-18.19M	-63.50%
Dec 31, 2021	28.65M	15.36M	115.61%
Dec 31, 2020	13.29M	449.00K	3.50%
Dec 31, 2019	12.84M	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-